Overall M(SD) Important or Very Important
Review of Data    
Data showing rising rates of prescription abuse 3.22 (.74) 83%
Data showing rising sales of prescription drugs 3.09 (.79) 74%
Review of Policies    
State/policy efforts to curb misuse/abuse 3.04 (.83) 78%
Workplace efforts to curb misuse/abuse 3.30 (.64) 91%
Tools    
How to read prescription labels 3.39 (.66) 91%
How the brain works with prescription drugs 3.43 (.66) 91%
Ways to read/respond to ads on such drugs 3.00 (.74) 74%
Special Populations    
Risks for teenagers and youth 3.22 (.74) 83%
Risks for women (e.g. pregnancy) 3.22 (.74) 83%
Risks for emerging adults (college) 3.22 (.74) 83%
Risks for military 3.00 (.80) 70%
Risks in workplace (e.g. health workers w/access) 3.35 (.71) 87%
Dealing with aging parents' prescription drugs 3.35 (.78) 83%
Table 4: Webinar content section importance: in-depth reviewers; Note: Ratings were on a 4-point scale from “Not Important” to “Very Important.” Sample size: 23